Continuing Challenges for Learning Disabled Students
Journal of Psychology & Clinical Psychiatry · 2014
DOI: 10.15406/jpcpy.2014.01.00011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Psychology & Clinical Psychiatry, 2014. Verfasst von Ronald C Naso.
Abstract (Originalsprache)
The answer to this question is disturbing, but relatively straight forward: many school systems have failed to adopt this new standard and rely instead on the pre-2004 criteria.In brief, these criteria require both the diagnosis of a disability (or disabling condition) and a demonstration that the condition has a significant educational impact.While continued reliance on these criteria may be appropriate for decision regarding special educational services, it is problematic when applied to eligibility for accommodations.In 2009, the definition of the term "disability" was broadened in a way that lowered the threshold for receiving accommodations (Public Law, 110-32s).Previously, children with conditions like myopia, diabetes, asthma, and/or Attention Deficit-Hyperactivity Disorder (ADHD) qualified only if a significant education impact could be documented in spite of medical treatment.The new statue now requires school districts to consider these disabling conditions independent of the individual's response to intervention.Thus, a child treated with Adder all for ADHD meets the standard for a disability because a positive response to medication can no longer be used to disqualify him.
Zitieren
APA
Naso, R. C. (2014). Continuing Challenges for Learning Disabled Students. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2014.01.00011
Vancouver
Naso RC. Continuing Challenges for Learning Disabled Students. Journal of Psychology & Clinical Psychiatry. 2014. doi:10.15406/jpcpy.2014.01.00011
BibTeX
@article{Naso2014,
author = {Naso, Ronald C},
title = {Continuing Challenges for Learning Disabled Students},
journal = {Journal of Psychology & Clinical Psychiatry},
year = {2014},
doi = {10.15406/jpcpy.2014.01.00011}
}
EUVIMED